The Connecticut-based firm funds and mentors a select number of healthcare startups committed to making a societal impact. Their portfolio includes companies that have decoded the Neanderthal genome, enabled the new age of molecular medicine, and developed promising new drugs for breast cancer. The startups are funded from the beginning for success, allowing them to exploit new developments in physics, math, and life sciences to create novel technologies and do first-of-its-kind science. 4Catalyzer's portfolio companies have been recognized as World Economic Forum Technology pioneers and Science Magazine's top innovations of the year.